Table 2

Differentially expressed miRNAs in PC-3 sphere cells of prostate cancer compared with PC-3 adherent cells by miRNA microarray and qRT-PCR
Down-regulation Fold change Up-regulation Fold change
Genes Microarray qRT-PCR Genes Microarray qRT-PCR
hsa-miR-143 10.3 8.4 ± 0.57 hsa -miR-202 11.8 7.9 ± 1.84
hsa -miR-19a* 6.8 7.1 ± 1.13 hsa -miR-96* 8.7 5.2 ± 2.37
hsa -miR-125b 6.4 5.8 ± 0.79 hsa -miR-377 3.9 4.0 ± 0.39
hsa -miR-16 3.2 3.8 ± 1.61 hsa -miR-802 4.7 3.7 ± 0.84
hsa -miR-675 2.2 3.1 ± 0.42 hsa -miR-606 4.4 3.2 ± 0.68
hsa -miR-92a 4.3 2.9 ± 0.73 hsa-miR-142 3.1 3.1 ± 0.32
hsa -miR- let-7i 5.1 2.8 ± 0.32 hsa-miR-590 4.1 3.0 ± 0.53
hsa -miR-34a 3.0 2.7 ± 0.29 hsa-miR-376c 3.4 2.8 ± 0.32
hsa -miR-616 2.9 2.7 ± 0.65 hsa-miR-19a 3.0 2.7 ± 0.34
hsa -miR-933 2.9 2.5 ± 0.51 hsa-miR-381 2.4 2.7 ± 0.54
hsa -miR-17 3.7 2.4 ± 0.27 hsa-miR-19b 2.8 2.5 ± 0.42
hsa -miR-365 2.6 2.4 ± 0.39 hsa-miR-28 3.2 2.4 ± 0.57
hsa -miR-135b* 2.6 2.3 ± 0.41 hsa-miR-488* 3.0 2.4 ± 0.38
hsa -miR-939 3.4 2.3 ± 0.69 hsa-miR-18b 2.1 2.3 ± 0.42
hsa-miR- let-7c* 2.4 2.2 ± 0.28 hsa-miR-137 2.7 2.3 ± 0.63
hsa -miR-24 2.3 2.1 ± 0.33 hsa-miR-216b 2.6 2.2 ± 0.28
hsa -miR-10a 2.3 2.1 ± 0.45 hsa-miR-337 2.0 2.1 ± 0.23
hsa -miR-205 4.2 2.0 ± 0.25 hsa-miR-30a 2.3 2.0 ± 0.45
hsa -miR-584 2.8 2.0 ± 0.49 hsa-miR-452* 2.3 1.8 ± 0.25
hsa -miR-125a 2.5 1.9 ± 0.39 hsa-miR-570 2.2 1.4 ± 0.39
hsa -miR-574 2.3 1.8 ± 0.64 hsa-miR-301b 2.1 1.3 ± 0.52
hsa -miR-361 2.2 1.7 ± 0.44 hsa-miR-379 2.1 1.0 ± 0.35
hsa -miR- let-7 g 2.2 1.7 ± 0.65 hsa-miR-22 2.0 0.9 ± 0.56
hsa -miR-885 2.2 1.5 ± 0.34 hsa-miR-545* 2.0 0.7 ± 0.44
hsa -miR-325 2.1 1.4 ± 0.39 hsa-miR-922 2.0 0.5 ± 0.29
hsa -miR-9* 2.1 1.3 ± 0.52
hsa -let-7c* 2.1 1.3 ± 0.26
hsa -miR-27b 2.0 1.2 ± 0.44
hsa -miR-296 2.3 1.1 ± 0.35
hsa -miR-630 2.0 1.1 ± 0.22
hsa-miR-138 2.0 1.0 ± 0.39
hsa-miR-936 2.0 1.0 ± 0.35
hsa-let-7e 2.0 1.0 ± 0.55
hsa-miR-513 2.0 0.9 ± 0.51
hsa-miR-135b* 2.1 0.9 ± 0.24
has-miR-845 2.0 0.8 ± 0.19

Fan et al.

Fan et al. BMC Cancer 2013 13:61   doi:10.1186/1471-2407-13-61

Open Data